Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/10/2003EP1368002A2 Method for producing a floating tablet containing alfuzosine
12/10/2003EP1368001A2 Pharmaceutical formulation comprising bicalutamide
12/10/2003EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367996A1 Sustained-release suspension of ceftiofur hydrochloride
12/10/2003EP1367992A2 Topical composition comprising a functionally alkylating cosmetic bonding agent
12/10/2003EP1367989A1 Use of a mixture designed to reduce secretion of sebum in a cosmetic or dermatological composition
12/10/2003EP1367987A2 Use of active-ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and/or uv-b wavelength range(s), for producing cosmetic or dermatological preparations
12/10/2003EP1367970A1 Alkyl aryl polyether alcohol polymers for improvement of nasal breathing
12/10/2003EP1367891A1 Pharmaceutical composition containing aminoacetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals
12/10/2003EP1367886A2 Scce modified transgenic mammals and their use as models of human disease
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1289364B1 Stable gabapentin containing more than 2o ppm of chlorine ion
12/10/2003EP1284263B1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents
12/10/2003EP1276477B1 Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1200393B1 Oxime amides and hydrazone amides having fungicidal activity
12/10/2003EP1189916B1 N-pyrazole a 2a receptor agonists
12/10/2003EP1187829B1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/10/2003EP1185276B1 Isophosphoramide mustard analogs and use thereof
12/10/2003EP1177191B1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
12/10/2003EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP1077992B1 Use of meiosis regulating compounds
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP1056710B1 Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
12/10/2003EP1039916B1 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies
12/10/2003EP1017365B1 Liposome-entrapped polynucleotide composition and method
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0966276B1 Use of beta-3 adrenergic receptor agonists for preparing wound-healing pharmaceuticals
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0935598B1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/10/2003EP0904060B1 Antifungal compositions with improved bioavailability
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003EP0893995B1 Anticachectic composition
12/10/2003EP0883400B1 Delivery system for localized administration of medicaments to the upper respiratory tract
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0828498B1 Chemotherapeutic compositions
12/10/2003EP0825867B1 N,o-carboxymethylchitosan for prevention of surgical adhesions
12/10/2003EP0795560B1 Keratan sulfate oligosaccharide fraction and drug containing the same
12/10/2003EP0778770B1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
12/10/2003EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives
12/10/2003EP0711169B1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0671924B1 Digitalis-like compounds
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/10/2003CN1461343A 多核苷酸 Polynucleotide
12/10/2003CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B
12/10/2003CN1461306A Thiazole Derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1461222A Behavior chemotherapy
12/10/2003CN1461219A Non-sedating barbiturate compounds as neuroprotective agents
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461217A Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1461213A 1-amino-alkylcyclohexanes as trypanocidal agents
12/10/2003CN1461212A Hydrogel-driven drug dosage form
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1461209A Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth
12/10/2003CN1461207A Vaginal delivery of bisphosphonates
12/10/2003CN1461188A Material for inproving living environment, and building material, laying material and spraying agent using the same
12/10/2003CN1460684A Epimedium extract and its production method
12/10/2003CN1460667A Pineapplie leaf extract, its preparation method and application
12/10/2003CN1460500A Fragrance body health-care product
12/10/2003CN1460485A New process for making animal medicine madumycin ammonium, ivermection or dikezhuli premixed agent
12/10/2003CN1460484A Bacillus prodigiosus polysaccharide for nose drops
12/10/2003CN1460483A Medicine for curing cerebrovascular diseases and its preparation method
12/10/2003CN1460482A Medicine composite containing icaritin and demethylicaritin and its application
12/10/2003CN1460481A Medicine composition using resveratrol glucodside for curing fatty liver and its preparation method
12/10/2003CN1460480A Hypoglycemic health-care food for diabetes type Ôàí"
12/10/2003CN1460479A New application of lactose derivative
12/10/2003CN1460478A Huangyangning slow-releasing preparation
12/10/2003CN1460477A Prpearation method of H2 receptor antagonist composite salt and its application
12/10/2003CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate
12/10/2003CN1460475A Sophoridine soft capsule for curing malignant tumor and its preparation method
12/10/2003CN1460474A Application of geldanamycin in preparation of medicine for curing SARS
12/10/2003CN1460473A Application of brataxin in preparation of medicine for inhibiting AIDS virus
12/10/2003CN1460472A Biquanide vanadium complex plaster preparation for curing diabetes and its application
12/10/2003CN1460471A Fenofibrate soft capsule and its preparation method
12/10/2003CN1460470A Dichlofenac sodium slow-releasing preparation and its preparation method
12/10/2003CN1460469A Preparation method of aspirin microsphere
12/10/2003CN1460467A Adriamycin liposome hydrochloride for injection
12/10/2003CN1130459C Biological active molecules having potentiating effect on growth hormone biological activity
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use